Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 2/20 | 0.55 |
| ▸ | FNTB | P49356 | 2/20 | 0.55 |
| ▸ | THRB | P10828 | 1/20 | 0.55 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.55 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.45 |
| ▸ | PPARG | P37231 | 7/20 | 0.45 |
| ▸ | PPARD | Q03181 | 7/20 | 0.45 |
| ▸ | PPARA | Q07869 | 7/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 2/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.45 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18606216 | 0.93 | FNTA (0.44) | FNTAFNTBTHRBPGGT1BGPR84 | |
| SCHEMBL11910003 | 0.91 | FNTA (0.56) | FNTAFNTBTHRBPGGT1BGPR84 | |
| SCHEMBL11910002 | 0.91 | FNTA (0.56) | FNTAFNTBTHRBPGGT1BGPR84 | |
| SCHEMBL1074447 | 0.89 | FNTA (0.53) | FNTAFNTBTHRBPGGT1BGPR84 | |
| SCHEMBL1074445 | 0.89 | FNTA (0.53) | FNTAFNTBTHRBPGGT1BGPR84 | |
| SCHEMBL540774 | 0.86 | FNTA (0.50) | FNTAFNTBTHRBPGGT1BGPR84 | |
| SCHEMBL540686 | 0.80 | FNTA (0.61) | FNTAFNTBTHRBPGGT1BGPR84 | |
| SCHEMBL13121532 | 0.78 | CES2 (0.42) | GPR84PPARGPPARDPPARAHDAC11 | |
| SCHEMBL183951 | 0.78 | FNTA (0.75) | FNTAFNTBTHRBPGGT1BGPR84 | |
| SCHEMBL1051704 | 0.78 | FNTA (0.75) | FNTAFNTBTHRBPGGT1BGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230138395-A1 | PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE AND METHODS OF THEIR USE | BIOSERGEN AS (NO) | 2023-05-04 | — | — | US | disclosed |
| EP-4110305-A1 | PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE AND METHODS OF THEIR USE | Biosergen AS (NO) | 2023-01-04 | — | — | EP | disclosed |
| EP-1647262-B2 | Anhydrous cosmetic composition comprising electrophilic monomers and acid, and use for cosmetic treatment of hair | OREAL (FR) | 2012-02-08 | — | — | EP | disclosed |
| EP-1647262-B1 | Anhydrous cosmetic composition comprising electrophilic monomers and acid, and use for cosmetic treatment of hair | OREAL (FR) | 2009-08-05 | — | — | EP | disclosed |
| EP-2065026-A1 | Composition comprising, in an anhydrous cosmetically acceptable medium, electrophilic monomers and an acid, and its use for cosmetic treatment of hair | L'Oreal (FR) | 2009-06-03 | — | — | EP | disclosed |
| EP-1649898-A2 | Dye composition comprising a pigment and at least one specific electrophilic monomer | L'OREAL (FR) | 2006-04-26 | — | — | EP | disclosed |
| EP-1649894-A2 | Composition comprising electrophilic monomers and organic salts, use for treatment of keratinic materials | L'OREAL (FR) | 2006-04-26 | — | — | EP | disclosed |
| EP-1649895-A2 | Oxidizing composition comprising at least one electrophilic monomer and an oxidant with exception of benzoquinone | L'OREAL (FR) | 2006-04-26 | — | — | EP | disclosed |
| EP-1649896-A2 | Dye composition comprising a mixtrure of pigment and electophilic monomer | L'OREAL (FR) | 2006-04-26 | — | — | EP | disclosed |
| EP-1649897-A2 | Dye composition comprising a pigment and at least an electrophilic monomer | L'OREAL (FR) | 2006-04-26 | — | — | EP | disclosed |
| EP-1647265-A1 | Use for the cosmetic treatment of keratinous material of non sticky compositions based on electrophilic monomeres and non-silicon polymers | L'OREAL (FR) | 2006-04-19 | — | — | EP | disclosed |
| EP-1647264-A1 | use for cosmetic treatment of keratinic material of a composition comprising an electrophilic monomer and a non-siloxane polymer, thereby achieving a rigid coating | L'OREAL (FR) | 2006-04-19 | — | — | EP | disclosed |
| EP-1647260-A1 | use for cosmetic treatment of keratinic material of a composition comprising an electrophilic monomer and a non-siloxane polymer, thereby achieving a soft coating | L'OREAL (FR) | 2006-04-19 | — | — | EP | disclosed |
| EP-1647259-A1 | use for treatment of keratinic materials of compositions comprising electrophilic monomers and agents forming liquid crystals | L'OREAL (FR) | 2006-04-19 | — | — | EP | disclosed |
| EP-1647258-A1 | Hair care composition based on electrophilic monomers and lubricating solid micro or nano particles | L'OREAL (FR) | 2006-04-19 | — | — | EP | disclosed |
| EP-1647263-A1 | Double chamber aerosol device comprising electrophilic monomers and use for the cosmetic treatment of hair | L'OREAL (FR) | 2006-04-19 | — | — | EP | disclosed |
| EP-1647261-A1 | Composition for the treatment of keratinous material based on electrophilic monomers and salts | L'OREAL (FR) | 2006-04-19 | — | — | EP | disclosed |
| EP-1647262-A1 | Anhyrous cosmetic composition comprising electrophilic monomers and acid, and use for cosmetic treatment of hair | L'OREAL (FR) | 2006-04-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230138395-A1 | PHARMACEUTICAL COMPOSITIONS OF A THERAPEUTIC POLYENE MACROLIDE AND METHODS OF THEIR USE | CEL, LIPA, HDAC6 | FNTA 475/4885FNTB 908/4885THRB 4581/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.